206A — PRISM Biolab Co Balance Sheet
0.000.00%
Last trade - 00:00- ¥7bn
- ¥4bn
- ¥677m
Annual balance sheet for PRISM Biolab Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
| Standards: | — | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 1,688 | 1,134 | 4,392 | 2,916 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 21.7 | 40.2 | 54.9 | 52.8 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1,732 | 1,198 | 4,483 | 3,039 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0 | 0 | 0 | 0 |
| Other Long Term Assets | ||||
| Total Assets | 1,740 | 1,211 | 4,529 | 3,086 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 65.1 | 63.2 | 1,020 | 370 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 65.2 | 63.4 | 1,026 | 377 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1,675 | 1,148 | 3,503 | 2,709 |
| Total Liabilities & Shareholders' Equity | 1,740 | 1,211 | 4,529 | 3,086 |
| Total Common Shares Outstanding |